Yes AZN had originally picked up 1/2 the cost. However MSK, with new grant monies, is now the 100% sponsor so that $TPIV and AZN are only providing the drugs and Collaborators advisory roles.
Thank you very much Phantom. It helps me to get a perspective from someone that has the knowledge that you do. Thanks again! If what i was reading about minimum uplist to Nasdaq being $4 per share, i would assume the minimum RS to be 1:10.